PHARMACYTE BIOTECH, INC. (PMCB) Stock buybacks 2022–2026
PHARMACYTE BIOTECH, INC. (PMCB) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$401,625FY2026 · since FY2022: $0 → $401,625
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $401,625 | -84.2% |
| FY2025 | $2.5M | -91.0% |
| FY2024 | $28.2M | +107.9% |
| FY2023 | $13.6M | — |
| FY2022 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PMCB financial trends
PMCB RevenuePMCB Net incomePMCB Net marginPMCB Gross profitPMCB Gross marginPMCB Operating incomePMCB Operating marginPMCB Operating cash flowPMCB Free cash flowPMCB Capital expendituresPMCB Return on equityPMCB Dividends paidPMCB Total assetsPMCB Total liabilitiesPMCB Shareholders’ equityPMCB overview →